CLINICAL_TRIALS
trial_result
· 2024-06-07
Clinical Trial Update: Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor
Summary
A real-world study evaluating palbociclib in combination with an aromatase inhibitor for metastatic breast cancer has completed, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Metastatic Breast Cancer | Status: COMPLETED | Results posted: 2024-06-07